PathAI Quarterly Newsletter
Summer 2024 ☀️
We're excited to share the latest advancements, achievements, and innovations from our team. In this issue, you'll discover how PathAI is continuing to revolutionize the field of pathology with cutting-edge AI technologies, groundbreaking research, and inspiring collaborations. Learn about the strides we've made in improving pathology, enhancing drug development, and shaping the future of healthcare.
Our Partnership with Quest Diagnostics
Learn more about our new partnership with Quest Diagnostics and the acquisition of PathAI Diagnostics to fuel a new era of pathology. Read More >>
New Foundation Model, PLUTO publication
Read our new publication highlighting our new Foundation Model aimed to accelerate the development of new AI-powered pathology products. Read More >>
Boston’s Best Place to Work 2024 Award
This year, we were selected as one of Boston’s Best Places to Work by the Boston Business Journal for 2024. Read More >>
.png "PathAI News (3)")
AISight® just got even better
Learn more about AISight® Version 2.9 with new guest access, accession notes, new annotations & sorting with algorithm updates to better ArtifactDetect™
Read More >>
.png "PathAI News (1)")
ASCO 2024 - Announcement PathExplore™ IOP and IHC Explore™
This year, we attended ASCO 2024 and debuted our two new algorithm products for Immuno-Oncology Profiling (IOP) and AI-powered biomarker discovery for Immunohistochemistry whole-slide images. View the posters and access our brochures. Read More >>
Publication in NPJ Precision Oncology - AI-Powered Nuclei Morphology
Read how the PathAI team developed a pan-tissue AI-powered digital pathology pipeline for segmentation, identification, and classification of nuclear features directly from H&E whole-slide images. Read More >>
New Demo Access to PathExplore™ IHC Explore™ and more
Try out AI-powered pathology platforms for all of our PathExplore algorithm products including PathExplore™ IOP to see the tumor microenvironment in high resolution. Read More >>
.png "PathAI News (2)")
Introducing Liver Explore™
Enhancing the discovery of novel biomarkers in MASH and other liver diseases with quantitative, cellular-level characterization of tissue and fibrosis microarchitecture in liver biopsies. Read More >>
EASL 2024 - Presentations & Highlights
Read our presentations highlighting AI-powered pathology for liver disease research and more about AIM-MASH™ for standardized and scalable histologic scoring for MASH clinical trials. Read More >>
Other News: We're Hiring!
We’re looking for new team members! Join our mission to improve patient outcomes with AI pathology, apply today.
View Open Positions >>
Cheers to a fantastic summer ahead,
The PathAI Team
PathExplore™ PathExplore™ IOP Liver Explore™ AISight® and IHC Explore™ are for research use only. Not for use in diagnostic procedures.
CASE STUDY
AI-Assisted Titer Selection in Early Assay Development
- PathAI deployed IHC Explore on prostate cancer specimens stained with a novel, in-development assay
- IHC Explore quantifies staining intensity at single-cell resolution, enabling rapid assay characterization and titer optimization
- Continuous staining intensity measurement provides added value for next-generation biomarkers and precision medicine strategies